
AbbVie stocks tumbled 14% yesterday after the FDA warned that two of the company’s hepatitis C drugs could cause serious …
The UK market has the potential to lead the world in digital health – if certain barriers are overcome – …

Merck’s recent rebrand may have left many scratching their heads, as the company moved away from the clinical professionalism of …

Gilead Sciences has today announced 96-week results from two Phase III studies evaluating its investigational once-daily single tablet regimen (STR), …

UK Healthcare guidance body NICE has today published final draft guidance recommending four drugs for the treatment of juvenile ideopathic …

UK Healthcare guidance body NICE has today published final draft guidance recommending four drugs for the treatment of juvenile ideopathic …

More than £2 billion of healthcare trade deals and collaborations have been signed between Chinese and UK companies, universities, and …

Digital marketing firm Physicians Interactive (PI) has acquired the Univadis medical information platform, in a move which it says creates …

Biogen has begun the search for a replacement for Tony Kingsley, former executive vice president of global commercial operations.Kingsley will …

Roche has reported strong sales growth for the first nine months of 2015 and revised its sales outlook to reflect …

The world’s largest ever clinical trial has been launched across the UK today, to discover whether taking aspirin every day …

Despite lower than predicted sales of its top-selling products, Biogen has achieved $2.8 billion in revenues in the third quarter …

Biogen’s natalizumab has failed to achieve clinical endpoints in a late-stage study to prove the drug’s potential in patients with …

Janssen is planning new regulatory submissions for Stelera after Phase III data found it improved responses and remission rates in …

DNA’s well-established medical communications practice will now offer fully integrated healthcare communications to its clients. Neil Flash remains DNA’s managing …

DNA’s well-established medical communications practice will now offer fully integrated healthcare communications to its clients. Neil Flash remains DNA’s managing …

GlobalData’s “Kidney Disease Global Clinical Trials Review, H2, 2015″ gives invaluable insight into the current state of clinical trials in …
Countries should step up their investment in long-term R&D to develop disruptive technologies that will reshape industry, healthcare and communications, …

NICE has published draft guidance recommending MSD’s Ezetrol as an option for some adults with high cholesterol. The guidance updates …

From Humira to Cubicin, some multi-billion dollar drugs are set to be hit hard by patent expiries next year, and …